Dépistage du cancer du col utérin au Canada : Rapport de surveillance 1998

[Précédente] [Table des matières] [Prochaine]

Références

1. Division du Cancer, Santé Canada, 2001.
2. Institut national du cancer du Canada. Statistiques canadiennes sur le cancer 1995. Toronto, Canada, 1995.
3. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol 1992;16(9):914-6.
4. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973;33(6):1353-67.
5. Harris RW, Brinton LA, Cowdell RH, Skegg DC, Smith PG, Vessey MP, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer 1980;42(3):359-69.
6. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989;44(2):199-203.
7. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2(8254):1010-5.
8. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85(12):958-64.
9. Kjaer SK, Nielsen NH. Cancer of the female genital tract in Circumpolar Inuit. Acta Oncol 1996;35(5):581-7.
10. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. Can Med Assoc J 2000;163(5):503-8.
11. Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol 1988; 17(3):501-8.
12. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. “Pap” smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet 1984;2(8406):779-82.
13. Winkelstein W Jr. Smoking and cervical cancer—current status: a review. Am J Epidemiol 1990;131(6):945-57; discussion 958-60.
14. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47(14):3886-8.
15. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76(10 Suppl):1888-901.
16. Brinton LA. Oral contraceptives and cervical neoplasia. Contraception 1991;43(6):581-95.
17. Schiffman MH, Brinton LA, Devessa SS, Fraumeni JF Jr. Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 1996;1090-116.
18. Franco EL. Epidemiology of uterine cancers. In: Meisels A, Morin C, editors. Cytopathology of the uterus. 2nd ed. Chicago: American Society of Clinical Pathologists; 1997;301-24.
19. Institut national du cancer du Canada. Statistiques canadiennes sur le cancer. Toronto, Canada, 2001.
20. T. Kue Young. Emergence of Chronic Disease. Dans : The Health of Native Americans. New York: Oxford University Press; 1994; 100-101.
21. Nielsen NH, Storm HH, Gaudette LA, Lanier AP. Cancer in Circumpolar Inuit 1969-1988. A summary. Acta Oncol 1996;35(5):621-8.
22. Institut national du cancer du Canada. Statistiques canadiennes sur le cancer. Toronto, Canada, 1991.
23. Young TK, Kliewer E, Blanchard J, Mayer T. Monitoring disease burden and preventive behavior with data linkage: cervical cancer among aboriginal people in Manitoba, Canada. Am J Public Health 2000;90(9):1466-8.
24. Chaudhry M. Cancer incidence, mortality and survival among status Indians in Ontario (dissertation). 1998 Toronto: University of Toronto.
25. Band PR, Gallagher RP, Threlfall WJ, Hislop TG, Deschamps M, Smith J. Rate of death from cervical cancer among native Indian women in British Columbia. Can Med Assoc J 1992;147(12):1802-4.
26. Hislop TG, Deschamps M, Band PR, Smith JM, Clarke HF. Participation in the British Columbia Cervical Cytology Screening Programme by Native Indian women. Can J Public Health 1992;83(5):344-345.
27. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, et al. International trends in incidence of cervical cancer: II. Squamouscell carcinoma. Int J Cancer 2000;86(3):429-435
28. Task Force on Cervical Cancer Screening Programs. Cervical cancer screening programs (The Walton Report). Can Med Assoc J 1976;114:1003-33.
29. Kassirer E. Impact of the Walton report on cervical cancer screening programs in Canada. Can Med Assoc J 1980;122(4):417-23.
30. Walton RJ, Allen, HH, Anderson, GH, et al. Cervical Cancer Screening Programs : Summary of the 1982 Canadian Task Force Report. Can Med Assoc J 1982;127:581-9.
31. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, et al. Report of a National Workshop on Screening for Cancer of the Cervix. Can Med Assoc J 1991;145(10):1301-25.
32. Morrison BJ. Screening for cervical cancer. Dans : Groupe d’étude canadien sur l’examen médical périodique. Guide canadien de médecine clinique préventive. Ottawa : Santé Canada,1994; 870-881.
33. Bowman JA, Sanson-Fisher R, Redman S. The accuracy of selfreported Pap smear utilisation. Soc Sci Med 1997;44(7):969-76.
34. Lee J, Parsons GF, Gentleman JF. Le non-respect des lignes directrices quant au test de Papanicolaou. Rapports sur la santé 1998;10(1):9-21.
35. Patnick J (éd.). NHS cervical screening programme review. Sheffield, United Kingdom, 1999.
36. Australian Institute of Health and Welfare (AIHW) 2000. Cervical Screening in Australia 1997-1998. AIHW Cat No. 9. Canberra: Australian Institute of Health and Welfare (Cancer Series number 14), 2000.
37. Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. Can Med Assoc J 2001;164(8):1151-2.
38. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75(4):536-545.
39. Boon ME, de Graaff Guilloud JC, Kok LP, Olthof PM, van Erp EJ. Efficacy of screening for cervical squamous and adenocarcinoma. The Dutch experience. Cancer 1987;59(4):862-6.
40. Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer 1995;71(4):894-7.
41. Buntinx F and Brouwers M. Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. BMJ 1996;313:1285-90.
42. Miller AB. Editorial: Failures of cervical cancer screening. Am J Public Health 1995;85:761-762.
43. Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148(5):685-90.
44. Benoit AG, Krepart GV, Lotocki RJ. Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix. Am J Obstet Gynecol 1984;148(5):690-4.
45. Sweet L, Tesch M, Dryer D, McAleer. Étude des antécédents d’examen cytologique du col de l’utérus à l’Île-du-Prince-Édouard chez les femmes pour lesquelles on a diagnostiqué un cancer du col, 1981-1986. Chron Dis Can 1991;12:1-3.
46. Anderson GH, Benedet JL, Le Riche JC, Matisic JP, Thompson JE. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992;80(1):1-4.
47. Stuart GC, McGregor SE, Duggan MA, Nation JG. Review of the screening history of Alberta women with invasive cervical cancer. Can Med Assoc J 1997;157(5):513-9.
48. Shaw P, Osboren RJ, Nishri D, Cherry N, Clark EA. Review of the cervical screening history of Ontario women with cancer of the cervix. Presented at the Society of Canadian Colposcopists Meeting Victoria, BC, June 27th 1998.
49. Prince Edward Island Pap Screening Program.
50. British Columbia Cervical Cancer Screening Program.
51. Quality Management Working Group - Cervical Cancer Prevention Network. Programmatic Guidelines for Screening for Cancer of the Cervix in Canada. Ottawa : Society of Gynecologic Oncologists of Canada, 1998.
52. Tamblay JL, Catlin G. Plan d’echantillonnage de l’Enquête nationale sur la santé de population. Rapports sur la santé 1995; 7(1)31-34.
53. Swain L, Catlin G. Enquête nationale sur la santé de la population: une enquête longitudinale. Rapports sur la santé 1999;10(4)73-79.
54. Band PR, Gaudette LA, Hill GB et coll. Développement du registre caandien du cancer : Incidence du cancer au Canada et dans les régions canadiennes, 1969 à 1998. Santé et Bien-être social Canada, Statistique Canada. Ottawa : Ministre d’Approvisionnements et Services Canada. 1993.
55. Gaudette LA, Lee J. L’Incidence du cancer au Canada : 1969-1993. Statistiques Canada cat. no. 82-566-XPB édition. Ottawa : Ministre de l’Industrie, 1997.
56. King HS, Wigle DT, Hill GB, Silins J. Uterine cancers in Alberta: trends of incidence and mortality. Can Med Assoc J 1982; 127:591-594.
57. Snider JA, Beauvais JE. Utilisation du frottis de Papanicolaou au Canada : Estimation basée sur une population admissible rajustée en fonction des antécédents d’hystérectomie. Chron Dis Can 1998;19:19-24.
58. Marret LD, Chiarelli AM, Nishri ED, Theis B. Cervical Cancer in Ontario 1971-1996. April 1999 Action Cancer Ontario, Toronto, Canada.

[Précédente] [Table des matières] [Prochaine]